This review covers the medicinal chemistry of designing shorter, more drug-like antimicrobial peptides from lactoferricin — covering minimum pharmacophore, selectivity optimization, and resistance to bacterial defenses.
Key findingMedicinal chemistry review of short lactoferricin-derived antibacterial peptides covering: minimal pharmacophore identification, selectivity optimizat
What the researchers found
Medicinal chemistry review of short lactoferricin-derived antibacterial peptides covering: minimal pharmacophore identification, selectivity optimization (bacteria vs human cells), proteolytic stability enhancement, and design rules for drug-like antimicrobial peptides.
Why it matters
Relevant for antimicrobial-peptides, peptide-design, infection.
How the study worked
review study on antimicrobial-peptides, peptide-design.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
The medicinal chemistry of short lactoferricin-based antibacterial peptides.
Current medicinal chemistry, 14(1), 1-18
Citation
Haug, B E; Strøm, M B; Svendsen, J S M. (2007). The medicinal chemistry of short lactoferricin-based antibacterial peptides.. Current medicinal chemistry, 14(1), 1-18.